- Home
- IBG vs ISPC Comparison
IBG vs ISPC Comparison
Compare IBG & ISPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IBG | ISPC |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | Australia | United States |
| Employees | 9 | N/A |
| Industry | Beverages (Production/Distribution) | Precision Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5M | 2.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | IBG | ISPC |
|---|---|---|
| Price | $3.79 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 130.7K | ★ 956.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $9,291,115.00 |
| Revenue This Year | N/A | $35.93 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.30 | $0.23 |
| 52 Week High | $6.50 | $2.16 |
Technical Indicators
Market Signals| Indicator | IBG | ISPC |
|---|---|---|
| Relative Strength Index (RSI) | 53.57 | 37.07 |
| Support Level | $3.61 | $0.23 |
| Resistance Level | $5.12 | $0.44 |
| Average True Range (ATR) | 0.59 | 0.03 |
| MACD | -0.13 | -0.00 |
| Stochastic Oscillator | 12.15 | 7.01 |
Price Performance
Historical ComparisonAbout IBG Innovation Beverage Group Limited Ordinary Shares
Innovation Beverage Group Ltd is a developer, manufacturer, marketer, exporter, and retailer of a growing beverage portfolio of 70 formulations across 14 alcoholic and non-alcoholic brands. The company's focus is on premium and super premium brands. The Group has two reportable geographic segments: Australia and the United States.
About ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.